316 reports of this reaction
3.9% of all PROPYLENE GLYCOL reports
#3 most reported adverse reaction
VISION BLURRED is the #3 most commonly reported adverse reaction for PROPYLENE GLYCOL, manufactured by Alcon Laboratories, Inc.. There are 316 FDA adverse event reports linking PROPYLENE GLYCOL to VISION BLURRED. This represents approximately 3.9% of all 8,103 adverse event reports for this drug.
Patients taking PROPYLENE GLYCOL who experience vision blurred should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
VISION BLURRED is moderately reported among PROPYLENE GLYCOL users, representing a notable but not dominant share of adverse events.
In addition to vision blurred, the following adverse reactions have been reported for PROPYLENE GLYCOL:
The following drugs have also been linked to vision blurred in FDA adverse event reports:
VISION BLURRED has been reported as an adverse event in 316 FDA reports for PROPYLENE GLYCOL. This does not prove causation, but indicates an association observed in post-market surveillance data.
VISION BLURRED accounts for approximately 3.9% of all adverse event reports for PROPYLENE GLYCOL, making it one of the most commonly reported side effect.
If you experience vision blurred while taking PROPYLENE GLYCOL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.